These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22020288)

  • 1. Drug discovery targeting human 5-HT(2C) receptors: residues S3.36 and Y7.43 impact ligand-binding pocket structure via hydrogen bond formation.
    Canal CE; Cordova-Sintjago TC; Villa NY; Fang LJ; Booth RG
    Eur J Pharmacol; 2011 Dec; 673(1-3):1-12. PubMed ID: 22020288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Serotonin 5-HT
    Rdova-Sintjago TC; Villa N; Canal C; Booth R
    Int J Quantum Chem; 2012 Jan; 112(1):. PubMed ID: 24244046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pharmacology and ligand docking studies reveal a single amino acid difference between mouse and human serotonin 5-HT2A receptors that impacts behavioral translation of novel 4-phenyl-2-dimethylaminotetralin ligands.
    Canal CE; Cordova-Sintjago T; Liu Y; Kim MS; Morgan D; Booth RG
    J Pharmacol Exp Ther; 2013 Dec; 347(3):705-16. PubMed ID: 24080681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (1R, 3S)-(-)-trans-PAT: a novel full-efficacy serotonin 5-HT2C receptor agonist with 5-HT2A and 5-HT2B receptor inverse agonist/antagonist activity.
    Booth RG; Fang L; Huang Y; Wilczynski A; Sivendran S
    Eur J Pharmacol; 2009 Aug; 615(1-3):1-9. PubMed ID: 19397907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenesis Analysis Reveals Distinct Amino Acids of the Human Serotonin 5-HT
    Liu Y; Canal CE; Cordova-Sintjago TC; Zhu W; Booth RG
    ACS Chem Neurosci; 2017 Jan; 8(1):28-39. PubMed ID: 27580242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration of the ligand binding site of the human 5-HT(4) receptor by site-directed mutagenesis and molecular modeling.
    Mialet J; Dahmoune Y; Lezoualc'h F; Berque-Bestel I; Eftekhari P; Hoebeke J; Sicsic S; Langlois M; Fischmeister R
    Br J Pharmacol; 2000 Jun; 130(3):527-38. PubMed ID: 10821780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the influence of 5-HT2c aminoacidic variants with the inhibitory action of serotonin inverse agonists and antagonists.
    Galeazzi R; Massaccesi L; Piva F; Principato G; Laudadio E
    J Mol Model; 2014 Mar; 20(3):2120. PubMed ID: 24562856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive activity of serotonin 2C receptors at G protein-independent signaling: modulation by RNA editing and antidepressants.
    Labasque M; Meffre J; Carrat G; Becamel C; Bockaert J; Marin P
    Mol Pharmacol; 2010 Nov; 78(5):818-26. PubMed ID: 20699324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
    Knight AR; Misra A; Quirk K; Benwell K; Revell D; Kennett G; Bickerdike M
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):114-23. PubMed ID: 15322733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of vabicaserin (SCA-136), a selective 5-hydroxytryptamine 2C receptor agonist.
    Dunlop J; Watts SW; Barrett JE; Coupet J; Harrison B; Mazandarani H; Nawoschik S; Pangalos MN; Ramamoorthy S; Schechter L; Smith D; Stack G; Zhang J; Zhang G; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 2011 Jun; 337(3):673-80. PubMed ID: 21402690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT2C receptor modulators: a patent survey.
    Lee J; Jung ME; Lee J
    Expert Opin Ther Pat; 2010 Nov; 20(11):1429-55. PubMed ID: 20849206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. We Need 2C but Not 2B: Developing Serotonin 2C (5-HT2C) Receptor Agonists for the Treatment of CNS Disorders.
    Cheng J; Kozikowski AP
    ChemMedChem; 2015 Dec; 10(12):1963-7. PubMed ID: 26507582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization.
    Thomsen WJ; Grottick AJ; Menzaghi F; Reyes-Saldana H; Espitia S; Yuskin D; Whelan K; Martin M; Morgan M; Chen W; Al-Shamma H; Smith B; Chalmers D; Behan D
    J Pharmacol Exp Ther; 2008 May; 325(2):577-87. PubMed ID: 18252809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of essential residues for binding and activation in the human 5-HT7(a) serotonin receptor by molecular modeling and site-directed mutagenesis.
    Impellizzeri AA; Pappalardo M; Basile L; Manfra O; Andressen KW; Krobert KA; Messina A; Levy FO; Guccione S
    Front Behav Neurosci; 2015; 9():92. PubMed ID: 26005408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT(2C) receptor agonists and the control of appetite.
    Halford JC; Harrold JA
    Handb Exp Pharmacol; 2012; (209):349-56. PubMed ID: 22249823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Support for 5-HT2C receptor functional selectivity in vivo utilizing structurally diverse, selective 5-HT2C receptor ligands and the 2,5-dimethoxy-4-iodoamphetamine elicited head-twitch response model.
    Canal CE; Booth RG; Morgan D
    Neuropharmacology; 2013 Jul; 70():112-21. PubMed ID: 23353901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacophore-directed homology modeling and molecular dynamics simulation of G protein-coupled receptor: study of possible binding modes of 5-HT2C receptor agonists.
    Zuo Z; Chen G; Luo X; Puah C; Zhu W; Chen K; Jiang H
    Acta Biochim Biophys Sin (Shanghai); 2007 Jun; 39(6):413-22. PubMed ID: 17558446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the human 5-HT4 receptor binding site: exploration of a hydrophobic pocket.
    Rivail L; Giner M; Gastineau M; Berthouze M; Soulier JL; Fischmeister R; Lezoualc'h F; Maigret B; Sicsic S; Berque-Bestel I
    Br J Pharmacol; 2004 Oct; 143(3):361-70. PubMed ID: 15351779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel structural insights for drug design of selective 5-HT(2C) inverse agonists from a ligand-biased receptor model.
    Renault N; Gohier A; Chavatte P; Farce A
    Eur J Med Chem; 2010 Nov; 45(11):5086-99. PubMed ID: 20880612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The serotonin 5-HT2A and 5-HT2C receptors interact with specific sets of PDZ proteins.
    Bécamel C; Gavarini S; Chanrion B; Alonso G; Galéotti N; Dumuis A; Bockaert J; Marin P
    J Biol Chem; 2004 May; 279(19):20257-66. PubMed ID: 14988405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.